RAC 11.1% $1.37 race oncology ltd

General Comments / Chat, page-2695

  1. 8,428 Posts.
    lightbulb Created with Sketch. 1386
    Yes $45m is a lot for proving up value. But are you saying that $45m is sufficient to do the P3 trials ourselves?

    Also Dr T has said several times that the "sweet spot" for a transaction is after P2.

    And IMO without a partnership Australian retail investors won't drive the SP high enough to achieve a full value TO bid cold turkey, irrespective how good the P2 outcomes are.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.